CVS Health Overview
Valuation check: CVS's ROE is 6.16%, below the Healthcare sector average of 11.15%.
Get informed when a big investor buys or sells
+ Follow6.16%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
CVS Health (CVS) currently reports a ROE of 6.16%. That is below the Healthcare sector average of 11.15%. Use the charts on this page to explore CVS Health's ROE history and peer comparisons.
CVS Health's ROE of 6.16% is lower than the Healthcare sector average of 11.15%. That is roughly 44.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but CVS Health's current 6.16% should be judged against Healthcare norms (sector average: 11.15%) and against CVS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 6.16%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for CVS Health, and consider following CVS for alerts when major investors trade the stock.
CVS Health is classified in the Healthcare sector. On ROE, it currently shows 6.16% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CVS with unrelated industries.
